EMCDDA Home
  • EN
Search

Table TDI-107. All clients entering outpatient treatment by primary drug and age at first use, 2011 or most recent year available

Part (v) All hypnotics and sedatives outpatient clients by country and age at first use

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium3751521024163187
Bulgaria05835511282250
Czech Republic1440513624832
Denmark5281022112511061
Germany4113713313210579561007834841267
Estonia:::::::::::
Ireland27753491064517028198
Greece925104110353457
Spain16421311010391794997806138944
France501071017561282528475275750
Italy2046563115238322112213
Cyprus0314520318119
Latvia3418124124396643109
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary5126127710665065
Malta:::::::::::
Netherlands1353563631151228244342586
Austria63099210158967
Poland4:1222::::::
Portugal53551421021122
Romania00101000202
Slovenia:::3:::::1:
Slovakia0652132423023
Finland614922010343165
Sweden547929159104122120212
United Kingdom648559728721216514411418421883482536
Croatia61371221::18:
Turkey:::::::::::
Norway31100001606
Total7851479901663543415296522556219287471
 

Notes:

: Indicates no data are available

(1) Data are from 2010.

(2) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(4) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(6) Data are from 1st of April 2010 to 31st March 2011.

For more information relative to the treatment centre type, please see Table TDI-7.

See also Table TDI-11 part(i), part(ii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Outpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013